IndiaMart
FIEO
Nebivolol HCL is a cardioselective beta-blocker used to manage hypertension and heart failure. Manufactured by BLUEPILL EXPRESS under WHO-GMP standards, this high-quality API is ideal for global third-party pharmaceutical formulations.
Nebivolol Hydrochloride (Nebivolol HCL) is a third-generation, highly selective β1-adrenergic receptor blocker with vasodilating properties. It is widely used for the treatment of essential hypertension and chronic heart failure, offering the dual benefits of blood pressure control and improved vascular function through nitric oxide-mediated vasodilation.
At BLUEPILL EXPRESS, we are committed to the high-standard manufacture and third-party export of Nebivolol HCL API, ensuring exceptional purity, safety, and compliance with global pharmaceutical norms. Our manufacturing facilities are WHO-GMP and ISO 9001:2015 certified, equipped to handle high-volume production with stringent quality control protocols.
WHO-GMP certified production by BLUEPILL EXPRESS
Cardioselective beta-blocker with vasodilatory action
Suitable for manufacturing tablets and fixed-dose combinations
Compliant with IP/BP/USP/EP pharmacopeial standards
Regulatory support includes COA, MSDS, stability data, and DMF (upon request)
- Essential Hypertension
- Chronic Heart Failure (mild to moderate)
- Cardiovascular Risk Reduction
- Adjunctive therapy in high-risk cardiac patients
Each batch of Nebivolol HCL is subjected to in-house and third-party analysis, including:
- Assay and purity testing
- Residual solvents
- Impurity profiling (including enantiomeric purity)
- Particle size distribution
- Microbial limits and stability analysis under ICH guidelines
BLUEPILL EXPRESS offers bulk supply of Nebivolol HCL API with tailored batch sizes, custom packaging solutions, and a well-structured export documentation process. Our products are widely trusted by pharmaceutical manufacturers across Asia, Africa, the Middle East, Latin America, and the CIS countries.
